From: Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial
Sex | Â |
Female | 8 |
Male | 4 |
Mean Years of Age (range) | 18 (12-29) |
Fitzpatrick's phototypes | Â |
   I | 1 |
   II | 0 |
   III | 0 |
   IV | 2 |
   V | 9 |
   VI | 0 |
Duration of disease, mean years (range) | 5.96 (2-17) |
Ethnicity | Â |
   Caucasian | 2 |
   South Asian | 9 |
   South American | 1 |
Disease activity | Â |
   Progressive | 7 |
   Non progressive | 5 |
Previous repigmentation | Â |
   after treatment | 11 |
   spontaneous | 0 |
   no repigmentation | 1 |
Depigmentation on scars | 5 |
Stress at onset | 2 |
Stress as precipitating factor | 2 |
Itch before lesions | 3 |
Vitiligo on genitals | 3 |
Thyroid disease | Â |
   Yes | 1 |
   No | 11 |
Thyroid antibodies | Â |
   Yes | 0 |
   No | 9 |
   unknown | 3 |
Family history of premature gray hair | 4 |
Family history of vitiligo | 3 |
Degree to which vitiligo affects everyday life (out of 10, 10 being the worst) (SD) | 3.7 (1.84) |
History of autoimmune disease | 0 |
Family history of thyroid or other autoimmune disease | 1 |
Halo Nevus | 0 |